Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:04 PM
Study NCT ID:
NCT05186558
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-07
First Post:
2021-12-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-01-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-23
First Submit QC Date:
None
Study First Post Date:
2022-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-03
Last Update Post Date:
2022-03-07
Last Update Post Date Type:
ACTUAL